BCMA and CD19 Targeted Fast Dual CART for Chromosomal Abnomalities High-risk BCMA+ Multiple Myeloma
Clinical trial NCT04617704 · UNKNOWN
Trial details
- NCT number
- NCT04617704
- Sponsor
- Shanghai Changzheng Hospital
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-01
- Primary completion
- 2021-12-31
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.